COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,718,179 | +4.8% | 76,876 | +0.8% | 0.01% | 0.0% |
| Q2 2023 | $1,639,494 | -4.1% | 76,291 | +7.0% | 0.01% | -12.5% |
| Q1 2023 | $1,709,719 | -20.9% | 71,268 | -23.5% | 0.01% | -20.0% |
| Q4 2022 | $2,161,567 | -2.9% | 93,171 | -33.0% | 0.01% | -16.7% |
| Q3 2022 | $2,227,000 | +2.2% | 139,018 | +13.1% | 0.01% | +9.1% |
| Q2 2022 | $2,178,000 | +7.5% | 122,898 | +23.5% | 0.01% | +37.5% |
| Q1 2022 | $2,026,000 | +291.9% | 99,519 | +355.0% | 0.01% | +300.0% |
| Q2 2021 | $517,000 | -5.5% | 21,871 | -5.2% | 0.00% | 0.0% |
| Q1 2021 | $547,000 | -36.4% | 23,071 | -46.2% | 0.00% | -50.0% |
| Q4 2020 | $860,000 | -7.2% | 42,921 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $927,000 | +16.5% | 44,516 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $796,000 | +30.5% | 45,476 | +21.7% | 0.00% | 0.0% |
| Q1 2020 | $610,000 | +58.9% | 37,360 | +132.0% | 0.00% | +100.0% |
| Q2 2018 | $384,000 | – | 16,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |